Sergeant, Martin J. http://orcid.org/0000-0001-7264-2668
Hughes, Jim R. http://orcid.org/0000-0002-8955-7256
Hentges, Lance http://orcid.org/0000-0001-6327-6774
Lunter, Gerton
Downes, Damien J. http://orcid.org/0000-0002-5034-0869
Taylor, Stephen http://orcid.org/0000-0002-3559-4334
Funding for this research was provided by:
Wellcome Trust (106130/Z/14/Z)
RCUK | Medical Research Council (MC_UU_00016/14)
Foundation for the National Institutes of Health (R24DK106766)
Alan Turing Institute (AfSMBPP1\100037)
Article History
Received: 14 September 2020
Accepted: 31 March 2021
First Online: 25 May 2021
Competing interests
: The authors declare the following competing interests: S.T. is founder and CSO of Zegami, J.H. is founder of Nucleome Therapeutics and G.L. is co-founder of Genomics plc. The remaining authors declare no competing interests.